Amneal Plans ‘Meaningful Additions’ To Its Generics Portfolio

As Company Sees Increase In Its Generics Sales And Overall Revenues

 
• By Akriti Seth
  
Business Growth
Amneal expects to file 25 to 30 ANDAs and launch 20 to 30 new products on an annual basis • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Generics

More from Products